Business · 13/04/2001Updated: 10/17/2026 · 1 min read
FDA Announces Collection of Information for Labeling of Human Prescription Drugs
Summary
The Food and Drug Administration (FDA) has submitted a proposal to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, which includes specific requirements for labeling human prescription drugs, including the addition of a 'Geriatric Use' subsection.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →